The role of androgen receptors in atherosclerosis

The role of androgen receptors in atherosclerosis Male disadvantage in cardiovascular health is well recognised. However, the influence of androgens on atherosclerosis, one of the major causes of many life-threatening cardiovascular events, is not well understood. With the dramatic increase in clinical prescription of testosterone in the past decade, concerns about the cardiovascular side-effects of androgen supplementation or androgen deprivation therapy are increasing. Potential atheroprotective effects of testosterone could be secondary to (aromatase-mediated) conversion into oestradiol or, alternatively, to direct activation of androgen receptors (AR). Recent development of animal models with cell-specific AR knockout has indicated a complex role for androgen action in atherosclerosis. Most studies suggest androgens are atheroprotective but the precise role of AR remains unclear. Increased use of AR knockout models should clarify the role of AR in atherogenesis and, thus, lead to exploitation of this pathway as a therapeutic target. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Molecular and Cellular Endocrinology Elsevier

The role of androgen receptors in atherosclerosis

10 pages
Read Article

Loading next page...
 
/lp/elsevier/the-role-of-androgen-receptors-in-atherosclerosis-2y9XGM14YE
Publisher
Elsevier
Copyright
Copyright © 2017 Elsevier Ltd
ISSN
0303-7207
D.O.I.
10.1016/j.mce.2017.10.006
Publisher site
See Article on Publisher Site

Abstract

Male disadvantage in cardiovascular health is well recognised. However, the influence of androgens on atherosclerosis, one of the major causes of many life-threatening cardiovascular events, is not well understood. With the dramatic increase in clinical prescription of testosterone in the past decade, concerns about the cardiovascular side-effects of androgen supplementation or androgen deprivation therapy are increasing. Potential atheroprotective effects of testosterone could be secondary to (aromatase-mediated) conversion into oestradiol or, alternatively, to direct activation of androgen receptors (AR). Recent development of animal models with cell-specific AR knockout has indicated a complex role for androgen action in atherosclerosis. Most studies suggest androgens are atheroprotective but the precise role of AR remains unclear. Increased use of AR knockout models should clarify the role of AR in atherogenesis and, thus, lead to exploitation of this pathway as a therapeutic target.

Journal

Molecular and Cellular Endocrinology – Elsevier

Published: Apr 15, 2018

References

  • Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness
    Adams, M.R.; Williams, J.K.; Kaplan, J.R.
  • Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits
    Alexandersen, P.; Haarbo, J.; Byrjalsen, I.; Lawaetz, H.; Christiansen, C.
  • Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit
    Arad, Y.; Badimon, J.J.; Badimon, L.; Hembree, W.C.; Ginsberg, H.N.
  • Trends in androgen prescribing in the United States, 2001 to 2011
    Baillargeon, J.; Urban, R.J.; Ottenbacher, K.J.; Pierson, K.S.; Goodwin, J.S.
  • Adverse events associated with testosterone administration
    Basaria, S.; Coviello, A.D.; Travison, T.G.; Storer, T.W.; Farwell, W.R.; Jette, A.M.
  • Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest?
    Bennett, M.R.; Littlewood, T.D.; Hancock, D.C.; Evan, G.I.; Newby, A.C.
  • Functional testosterone receptors in plasma membranes of T cells
    Benten, W.P.; Lieberherr, M.; Giese, G.; Wrehlke, C.; Stamm, O.; Sekeris, C.E.
  • Mechanisms of plaque formation and rupture
    Bentzon, J.F.; Otsuka, F.; Virmani, R.; Falk, E.
  • Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis
    Bonnet, S.; Paulin, R.; Sutendra, G.; Dromparis, P.; Roy, M.; Watson, K.O.
  • Androgen receptor-dependent and independent atheroprotection by testosterone in male mice
    Bourghardt, J.; Wilhelmson, A.S.K.; Alexanderson, C.; De Gendt, K.; Verhoeven, G.; Krettek, A.
  • Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits
    Bruck, B.; Brehme, U.; Gugel, N.; Hanke, S.; Finking, G.; Lutz, C.
  • Testosterone treatment and coronary artery plaque volume in older men with low testosterone
    Budoff, M.J.; Ellenberg, S.S.; Lewis, C.E.; Mohler, E.R.; Wenger, N.K.; Bhasin, S.
  • Angiogenesis in the atherosclerotic plaque
    Camare, C.; Pucelle, M.; Negre-Salvayre, A.; Salvayre, R.
  • Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol
    Campelo, A.E.; Cutini, P.H.; Massheimer, V.L.
  • Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors
    Chang, C.S.; Kokontis, J.; Liao, S.T.
  • Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery
    Chen, S.J.; Li, H.; Durand, J.; Oparil, S.; Chen, Y.F.
  • Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation
    Claessens, F.; Verrijdt, G.; Schoenmakers, E.; Haelens, A.; Peeters, B.; Verhoeven, G.
  • New selective estrogen and androgen receptor modulators
    Clarke, B.L.; Khosla, S.
  • Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway
    Death, A.K.; McGrath, K.C.Y.; Sader, M.A.; Nakhla, S.; Jessup, W.; Handelsman, D.J.
  • A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis
    De Gendt, K.; Swinnen, J.V.; Saunders, P.T.K.; Schoonjans, L.; Dewerchin, M.; Devos, A.; Tan, K.; Atanassova, N.; Claessens, F.; Lecureuil, C.; Heyns, W.; Carmeliet, P.; Guillou, F.; Sharpe, R.M.; Verhoeven, G.
  • Cardiovascular toxicities of performance-enhancing substances in sports
    Dhar, R.; Stout, C.W.; Link, M.S.; Homoud, M.K.; Weinstock, J.; Estes, N.A.M.
  • Androgens and coronary artery disease. Chapter 16
    Dixit, K.C.S.; Wu, J.; Smith, L.B.; Hadoke, P.W.F.; Wu, F.C.W.
  • Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation
    Eich, D.M.; Nestler, J.E.; Johnson, D.E.; Dworkin, G.H.; Ko, D.; Wechsler, A.S.
  • The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice
    Fagman, J.B.
  • Coronary plaque disruption
    Falk, E.; Shah, P.K.; Fuster, V.
  • Non-genomic actions of androgens
    Foradori, C.D.; Weiser, M.J.; Handa, R.J.
  • Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathway
    Foresta, C.; Zuccarello, D.; De Toni, L.; Garolla, A.; Caretta, N.; Ferlin, A.
  • A UK epidemic of testosterone prescribing, 2001-2010
    Gan, E.H.; Pattman, S.H.P.; Quinton, R.
  • Chemistry and structural biology of androgen receptor
    Gao, W.; Bohl, C.E.; Dalton, J.T.
  • Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury
    Gordon, G.B.; Bush, D.E.; Weisman, H.F.
  • Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam Study
    Hak, A.E.; Witteman, J.C.M.; De Jong, F.H.; Geerlings, M.I.; Hofman, A.; Pols, H.A.P.
  • Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall
    Hanke, H.; Lenz, C.; Hess, B.; Spindler, K.D.; Weidemann, W.
  • Inflammation, atherosclerosis, and coronary artery disease
    Hansson, G.K.
  • Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells
    Hatakeyama, H.; Nishizawa, M.; Nakagawa, A.; Nakano, S.; Kigoshi, T.; Uchida, K.
  • Endogenous androgen deficiency enhances diet-induced hypercholesterolemia and atherosclerosis in low-density lipoprotein receptor-deficient mice
    Hatch, N.W.; Srodulski, S.J.; Chan, H.W.; Zhang, X.; Tannock, L.R.; King, V.L.
  • Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide
    Hayashi, T.; Tsaki, T.; Muto, E.; Kano, H.; Asai, Y.; Thakur, N.K.
  • A frame-shift mutation in the androgen receptor gene causes complete androgen insensitivity in the testicular-feminized mouse
    He, W.W.; Kumar, M.V.; Tindall, D.J.
  • Androgen receptor (AR) coregulators: an overview
    Heinlein, C.A.; Chang, C.
  • Experimental rat and mouse carotid artery surgery: injury & remodeling studies
    Holt, A.W.; Tulis, D.A.
  • Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids
    Horwitz, K.B.; Horwitz, L.D.
  • New therapy via targeting androgen receptor in monocytes/macrophages to battle atherosclerosis
    Huang, C.K.; Pang, H.; Wang, L.; Niu, Y.; Luo, J.; Chang, E.
  • Androgen receptor (AR) in cardiovascular diseases
    Huang, C.-K.; Lee, S.-O.; Chang, E.; Pang, H.; Chang, C.
  • Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury
    Ii, M.; Hoshiga, M.; Negoro, N.; Fukui, R.; Nakakoji, T.; Kohbayashi, E.
  • Nuclear import of the human androgen receptor
    Jenster, G.; Trapman, J.; Brinkmann, A.O.
  • The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
    Jones, T.H.; Saad, F.
  • Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminished mouse
    Jones, R.D.; Pugh, P.J.; Hall, J.; Channer, K.S.; Jones, T.H.
  • The influence of testosterone upon vascular reactivity
    Jones, R.D.; Jones, T.H.; Channer, K.S.
  • Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study
    Kaplan, H.; Thompson, R.C.; Trumble, B.C.; Wann, L.S.; Allam, A.H.; Beheim, B.; Frohlich, B.; Sutherland, M.L.; Sutherland, J.D.; Stieglitz, J.; Rodriguez, D.E.; Michalik, D.E.; Rowan, C.J.; Lombardi, G.P.; Bedi, R.; Garcia, A.R.; Min, J.K.; Narula, J.; Finch, C.E.; Gurven, M.; Thomas, G.S.
  • New Insights into the Tyrolean man's origin and phenotype as inferred by whole genome sequencing
    Keller, A.; Graefens, A.; Ball, M.; Matzas, M.; Boisguerin, V.; Maixner, F.
  • Quantitative 3-dimensional imaging of murine neointimal and atherosclerotic lesions by optical projection tomography
    Kirkby, N.S.; Low, L.; Seckl, J.R.; Walker, B.R.; Webb, D.J.; Hadoke, P.W.F.
  • Testosterone and cardiovascular disease
    Kloner, R.A.; Carson, C.; Dobs, A.; Kopecky, S.; Mohler, E.R.
  • Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels
    Larsen, B.A.; Nordestgaard, B.G.; Stender, S.; Kjeldsen, K.
  • The therapeutic value of testosterone propionate in angina pectoris
    Levine, S.A.; Likoff, W.B.
  • Regulation of atherosclerotic plaque growth and stability by testosterone and its receptor via influence of inflammatory reaction
    Li, S.; Li, X.; Li, Y.
  • Inflammation and immunity in diseases of the arterial tree. Players and layers
    Libby, P.; Hansson, G.K.
  • Sex hormones, insulin, lipids, and prevalent ischemic heart disease
    Lichtenstein, M.J.; Yarnell, J.W.; Elwood, P.C.; Beswick, A.D.; Sweetnam, P.M.; Marks, V.
  • Androgens and cardiovascular disease
    Liu, P.Y.; Death, A.K.; Handelsman, D.J.
  • Testosterone induces apoptosis in vascular smooth muscle cells via extrinsic apoptotic pathway with mitochondria-generated reactive oxygen species involvement
    Lopes, R.A.M.; Neves, K.B.; Pestana, C.R.; Queiroz, A.L.; Zanotto, C.Z.; Chignalia, A.Z.
  • Cloning of human androgen receptor complementary DNA and localization to the X chromosome
    Lubahn, D.B.; Joseph, D.R.; Sullivan, P.M.; Willard, H.F.; French, F.S.; Wilson, E.M.
  • X-linked gene for testicular feminization in the mouse
    Lyon, M.F.; Hawkes, S.G.
  • Testosterone as a protective factor against atherosclerosis - immunomodulation and influence upon plaque development and stability
    Malkin, C.J.; Pugh, P.J.; Jones, R.D.; Jones, T.H.; Channer, K.S.
  • Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer. A nested case-control study in UK primary care
    Martin-Merino, E.; Johansson, S.; Morris, T.; Garcia-Rodriguez, L.A.
  • Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations
    Matias, P.M.; Donner, P.; Coelho, R.; Thomaz, M.; Peixoto, C.; Macedo, S.
  • Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1
    McCrohon, J.A.; Jessup, W.; Handelsman, D.J.; Celermajer, D.S.
  • Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis
    McCrohon, J.A.; Death, A.K.; Nakhla, S.; Jessup, W.; Handelsman, D.J.; Stanley, K.K.
  • Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels
    McRobb, L.; Handelsman, D.J.; Heather, A.K.
  • Angiogenesis in atherosclerosis: gathering evidence beyond speculation
    Moulton, K.S.
  • Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice
    Moulton, K.S.; Heller, E.; Konerding, M.A.; Flynn, E.; Palinski, W.; Folkman, J.
  • Aromatase in atherosclerotic lesions of human aorta
    Murakami, H.; Harada, N.; Sasano, H.
  • Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase
    Nathan, L.; Shi, W.; Dinh, H.; Mukherjee, T.K.; Wang, X.; Lusis, A.J.
  • Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor
    Nettleship, J.E.; Jones, T.H.; Channer, K.S.; Jones, R.D.
  • Fibrous cap formation or destruction–the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation
    Newby, A.C.; Zaltsman, A.B.
  • Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells
    Norata, G.D.; Tibolla, G.; Seccomandi, P.M.; Poletti, A.; Catapano, A.L.
  • Dihydrotestosterone suppresses foam cell formation and attenuates atherosclerosis development
    Qiu, Y.; Yanase, T.; Hu, H.; Tanaka, T.; Nishi, Y.; Liu, M.
  • Dihydrotestosterone inhibits lectin-like oxidized-LDL receptor-1 expression in aortic endothelial cells via a NF-κB/AP-1-mediated mechanism
    Qiu, Y.; Tanaka, T.; Nawata, H.; Yanase, T.
  • Non-classical actions of testosterone: an update
    Rahman, F.; Christian, H.C.
  • Expression of Androgen Receptor Target Genes in Skeletal Muscle
    Rana, K.; Lee, N.K.L.; Zajac, J.D.; Maclean, H.E.
  • Atherosclerosis–an inflammatory disease
    Ross, R.
  • A sex-specific role for androgens in angiogenesis
    Sieveking, D.P.; Lim, P.; Chow, R.W.Y.; Dunn, L.L.; Bao, S.; McGrath, K.C.Y.
  • Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E
    Smith, J.D.; Trogan, E.; Ginsberg, M.; Grigaux, C.; Tian, J.; Miyata, M.
  • A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis
    Stary, H.C.; Chandler, A.B.; Glagov, S.; Guyton, J.R.; Insull, W.; Rosenfeld, M.E.
  • Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine
    Tharp, D.L.; Masseau, I.; Ivey, J.; Ganjam, V.K.; Bowles, D.K.
  • Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations
    Thompson, R.C.; Allam, A.H.; Lombardi, G.P.; Wann, L.S.; Sutherland, M.L.; Sutherland, J.D.
  • Ultrastructural changes in the comb and aorta of chicks fed excess testosterone
    Toda, T.; Toda, Y.; Cho, B.H.; Kummerow, F.A.
  • Mouse spermatogenesis requires classical and nonclassical testosterone signaling
    Toocheck, C.; Clister, T.; Shupe, J.; Crum, C.; Ravindranathan, P.; Lee, T.-K.; Ahn, J.-M.; Raj, G.V.; Sukhwani, M.; Orwig, K.E.; Walker, W.H.
  • Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor α
    Villablanca, A.; Lubahn, D.; Shelby, L.; Lloyd, K.; Barthold, S.
  • Increased intimal hyperplasia after vascular injury in male androgen receptor-deficient mice
    Wilhelmson, A.S.
  • Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs
    Williams, M.R.; Ling, S.; Dawood, T.; Hashimura, K.; Dai, A.; Li, H.
  • Effects of androgen treatment on the male rat aorta
    Wolinsky, H.
  • Modulation of neointimal lesion formation by endogenous androgens is independent of vascular androgen receptor
    Wu, J.; Hadoke, P.W.F.; Mair, I.; Lim, W.G.; Miller, E.; Denvir, M.A.
  • Influence of androgen receptor in vascular cells on reperfusion following hindlimb ischaemia
    Wu, J.; Hadoke, P.W.F.; Takov, K.; Korczak, A.; Denvir, M.A.; Smith, L.B.
  • Androgens and coronary artery disease
    Wu, F.C.W.; Von Eckardstein, A.
  • Effect of dehydroepiandrosterone on atherosclerosis in apolipoprotein E-deficient mice
    Yamakawa, T.; Ogihara, K.; Kakamura, M.; Utsunomiya, H.; Kadonosono, K.; Kishikawa, S.
  • Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues
    Yeh, S.; Tsai, M.-Y.; Xu, Q.; Mu, X.-M.; Lardy, H.; Huang, K.-E.
  • Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/Akt pathway
    Yu, J.; Akishita, M.; Eto, M.; Ogawa, S.; Son, B.K.; Kato, S.
  • Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?
    Zareba, P.; Duivenvoorden, W.; Leong, D.P.; Pinthus, J.H.
  • Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies
    Zhao, J.; Zhu, S.; Sun, L.; Meng, F.; Zhao, L.; Zhao, Y.
  • Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification
    Zhu, D.; Hadoke, P.W.F.; Wu, J.; Vesey, A.T.; Lerman, D.A.; Dweck, M.R.; Newby, D.E.; Smith, L.B.; MacRae, V.E.

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off

Sign up
for free
Start 14 day
Free Trial